Device-based approaches to pain management are seeing a renaissance of interest as the ongoing opioid crisis highlights the perils and limitations of existing drug treatments. Cleveland, Ohio-based SPR Therapeutics LLC is among the latest beneficiaries of that momentum with its new $25 million series C financing. Read More
